FDA's Sharfstein Asks School of Pharmacy to Help Agency Effectively Use New Regulatory Tools
Monday, October 11, 2010 - 12:30
in Health & Medicine
FDA has approved 146 medications under REMS, and added flexibility helped FDA resolve complex, controversial cases, e.g. rosiglitazone.